RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
ExpreS2ion Biotech Holding Stock

ExpreS2ion Biotech Holding Liabilities 2024

ExpreS2ion Biotech Holding Liabilities

13.33 M SEK

Ticker

EXPRS2.ST

ISIN

SE0008348262

WKN

A2APAB

In 2024, ExpreS2ion Biotech Holding's total liabilities amounted to 13.33 M SEK, a -60.84% difference from the 34.04 M SEK total liabilities in the previous year.

ExpreS2ion Biotech Holding Aktienanalyse

What does ExpreS2ion Biotech Holding do?

ExpreS2ion Biotech Holding ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing ExpreS2ion Biotech Holding's Liabilities

ExpreS2ion Biotech Holding's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating ExpreS2ion Biotech Holding's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing ExpreS2ion Biotech Holding's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

ExpreS2ion Biotech Holding's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in ExpreS2ion Biotech Holding’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about ExpreS2ion Biotech Holding stock

What is the level of liabilities of ExpreS2ion Biotech Holding this year?

ExpreS2ion Biotech Holding has a debt balance of 13.33 M SEK this year.

What were the liabilities of ExpreS2ion Biotech Holding compared to the previous year?

The liabilities of ExpreS2ion Biotech Holding have increased by -60.84% dropped compared to the previous year.

What are the consequences of high debt for investors of ExpreS2ion Biotech Holding?

High liabilities can pose a risk for investors of ExpreS2ion Biotech Holding, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in ExpreS2ion Biotech Holding?

Low liabilities mean that ExpreS2ion Biotech Holding has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of ExpreS2ion Biotech Holding affect the company?

An increase in liabilities of ExpreS2ion Biotech Holding can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of ExpreS2ion Biotech Holding affect the company?

A decrease in the liabilities of ExpreS2ion Biotech Holding can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of ExpreS2ion Biotech Holding?

Some factors that can influence the liabilities of ExpreS2ion Biotech Holding include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of ExpreS2ion Biotech Holding so important for investors?

The liabilities of ExpreS2ion Biotech Holding are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can ExpreS2ion Biotech Holding take to modify the liabilities?

To change its liabilities, ExpreS2ion Biotech Holding can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does ExpreS2ion Biotech Holding pay?

Over the past 12 months, ExpreS2ion Biotech Holding paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ExpreS2ion Biotech Holding is expected to pay a dividend of 0 SEK.

What is the dividend yield of ExpreS2ion Biotech Holding?

The current dividend yield of ExpreS2ion Biotech Holding is .

When does ExpreS2ion Biotech Holding pay dividends?

ExpreS2ion Biotech Holding pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of ExpreS2ion Biotech Holding?

ExpreS2ion Biotech Holding paid dividends every year for the past 0 years.

What is the dividend of ExpreS2ion Biotech Holding?

For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.

In which sector is ExpreS2ion Biotech Holding located?

ExpreS2ion Biotech Holding is assigned to the 'Health' sector.

Wann musste ich die Aktien von ExpreS2ion Biotech Holding kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ExpreS2ion Biotech Holding from 10/10/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 10/10/2024.

When did ExpreS2ion Biotech Holding pay the last dividend?

The last dividend was paid out on 10/10/2024.

What was the dividend of ExpreS2ion Biotech Holding in the year 2023?

In the year 2023, ExpreS2ion Biotech Holding distributed 0 SEK as dividends.

In which currency does ExpreS2ion Biotech Holding pay out the dividend?

The dividends of ExpreS2ion Biotech Holding are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von ExpreS2ion Biotech Holding

Our stock analysis for ExpreS2ion Biotech Holding Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ExpreS2ion Biotech Holding Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.